IP Verse

Octapharma patent opposition analysis

Get complete Patent Opposition Report for Octapharma

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest oppositions filed by Octapharma

Explore patent oppositions filed by Octapharma against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3794013Method And System Of Protein ExtractionCSL BEHRINGNov 21, 2024
EP3226895Pharmaceutical Product With Increased Stability Comprising ImmunoglobulinsCSL BEHRINGApr 22, 2021
EP2538975Immunoglobulin Preparation And Storage System For An Immunoglobulin PreparationCSL BEHRINGJun 18, 2020
EP3116534Compositions Of Human Prothrombin And Activated Factor X For Improving Hemostasis In The Treatment Of Bleeding DisordersBAXALTAFeb 28, 2020
EP2345425Immunoglobulin G (Igg) Concentrate Depleted Of Anti-A And Anti-B Antibodies And Of Polyreactive IggsLABORATOIRE FRANAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIESApr 11, 2019
EP2968434C1-Inh Compositions And Methods For The Prevention And Treatment Of Disorders Associated With C1 Esterase Inhibitor DeficencySHIRE VIROPHARMAMar 28, 2018

Latest patents of Octapharma opposed by its competitors

Explore Octapharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3626737Nov 29, 2023A Method Of Increasing The Productivity Of Eucaryotic Cells In The Production Of Recombinant Fviii2
EP2707387Dec 25, 2019A Method Of Increasing The Productivity Of Eucaryotic Cells In The Production Of Recombinant Fviii1
EP2640413Jun 12, 2019A Process For Reduction And/Or Removal Of Fxi And Fxia From Solutions Containing Said Coagulation Factors1
EP2670429Apr 4, 2018Method For Inactivation/Removal Of Coagulation Factors By Precipitation2
EP2825555Jul 12, 2017Improved Process For Production Of Fibrinogen And Fibrinogen Produced Thereby2

Top competitors of Octapharma